Sonoma Pharmaceuticals, Inc. Contracts & Agreements

254 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Distribution Agreement, dated August 19, 2024, by and between Sonoma Pharmaceuticals, Inc. and Medline Industries, LP
Distribution Agreements
Sonoma Pharmaceuticals, Inc.
2024
Amendment No. 1 to Equity Distribution Agreement, by and between Sonoma Pharmaceuticals, Inc. and Maxim Group LLC., dated March 8, 2024
Equity Distribution Agreements
Sonoma Pharmaceuticals, Inc.
2024
Offer letter to Jerome Dvonch dated February 7, 2024
Sonoma Pharmaceuticals, Inc.
2024
Offer letter to John Dal Poggetto dated February 7, 2024
Sonoma Pharmaceuticals, Inc.
2024
License and Distribution Agreement, dated January 5, 2024, by and between Sonoma Pharmaceuticals, Inc. and NovaBay Pharmaceuticals, Inc
License Agreements
Sonoma Pharmaceuticals, Inc.
2024
Equity Distribution Agreement, by and between Sonoma Pharmaceuticals, Inc. and Maxim Group LLC., dated December 15, 2023
Equity Distribution Agreements
Sonoma Pharmaceuticals, Inc.
2023
Boulder Lease Agreement between the Company and Westland Development Services, Inc., dated February 19, 2021
Lease Agreements
Sonoma Pharmaceuticals, Inc.
2023
First Amendment to the Lease between the Company and Westland Development Services, Inc, dated June 21, 2023
Lease Agreements
Sonoma Pharmaceuticals, Inc.
2023
Form of Placement Agency Agreement
Agency Agreements
Sonoma Pharmaceuticals, Inc.
2023
Form of Securities Purchase Agreement
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
2023
Offer letter to John Dal Poggetto dated July 11, 2023
Sonoma Pharmaceuticals, Inc.
2023
Consulting Agreement, by and between the Company and Jerome Dvonch Consulting, LLC, effective August 15, 2023
Consulting Agreements
Sonoma Pharmaceuticals, Inc.
2023
Amended and Restated Employment Agreement by and between the Company and Amy Trombly, dated June 16, 2023
Employment Agreements
Sonoma Pharmaceuticals, Inc.
2023
Amended and Restated Employment Agreement by and between the Company and Bruce Thornton, dated June 16, 2023
Employment Agreements
Sonoma Pharmaceuticals, Inc.
2023
Consulting Agreement, by and between the Company and Jerome Dvonch, dated April 7, 2023
Consulting Agreements
Sonoma Pharmaceuticals, Inc.
2023
Amendment to At-The-Market Offering Agreement, by and between the Company and Ladenburg Thalmann & Co. Inc., dated February 24, 2023
Sonoma Pharmaceuticals, Inc.
2023
Exclusive Distribution and Supply Agreement, dated January 26, 2023, by and between Sonoma Pharmaceuticals, Inc. and Daewoong Pharmaceutical Co., Ltd
Supply Agreements
Sonoma Pharmaceuticals, Inc.
2023
SONOMA PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM AND STOCK OWNERSHIP GUIDELINES Revised by the Board of Directors on December29, 2022
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2022
At-The-Market Offering Agreement, by and between the Company and Ladenburg Thalmann & Co. Inc., dated December 23, 2022
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2022
Offer letter to Chad White dated September 8, 2022
Sonoma Pharmaceuticals, Inc.
2022
Amended and Restated Employment Agreement by and between the Company and Amy Trombly, dated July 22, 2022
Employment Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CO
2022
Amended and Restated Employment Agreement by and between the Company and Bruce Thornton, dated July 22, 2022
Employment Agreements
Sonoma Pharmaceuticals, Inc.
2022
Non-Exclusive Distribution and Supply Agreement between Sonoma Pharmaceuticals, Inc. and Salus Medical, LLC dated January 19, 2022
Supply Agreements
Sonoma Pharmaceuticals, Inc.
2022
Exclusive License and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Anlicare International dated January 18, 2022
License Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
GA
2022
Exclusive License and Distribution Agreement between the Company and Dyamed Biotech Pte, Ltd., dated November 4, 2021
License Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
GA
2021
At-The-Market Offering Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated July 30, 2021
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
Employment Agreement by and between the Company and Amy Trombly, dated July 1, 2021
Employment Agreements
Sonoma Pharmaceuticals, Inc.
2021
Employment Agreement by and between the Company and Jerry Dvonch, dated July 1, 2021
Employment Agreements
Sonoma Pharmaceuticals, Inc.
2021
Employment Agreement by and between the Company and Bruce Thornton, dated July 1, 2021
Employment Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2021
Exclusive Supply and Distribution Agreement between the Company and EMC Pharma, LLC, dated March 26, 2021
Supply Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
GA
2021
Addendum to Employment Agreement with Amy Trombly, dated January 4, 2020
Employment Agreements
Sonoma Pharmaceuticals, Inc.
2021
Licensing and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Gabriel Science, LLC, effective December 14, 2020
Distribution Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
GA
2020
Exclusive Licensing and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Crown Laboratories, Inc., effective December 4, 2020
Distribution Agreements
Sonoma Pharmaceuticals, Inc.
2020
Offer letter J. Dvonch dated August 10, 2020
Sonoma Pharmaceuticals, Inc.
2020
Amendment No. 1 to the Consulting Agreement between the Company and TechCXO, LLC dated September 10, 2020
Consulting Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
GA
2020
Licensing Agreement between Sonoma Pharmaceuticals, Inc. and Microsafe Group, effective July 27, 2020
Sonoma Pharmaceuticals, Inc.
2020
Amendment No. 9 to Office Lease Agreement between the Company and SSCOP Properties LLC, dated June 20, 2020
Lease Agreements
Sonoma Pharmaceuticals, Inc.
2020
Woodstock Lease Agreement between the Company and Fowler Crossing Partners, LP, dated October 1, 2018
Lease Agreements
Sonoma Pharmaceuticals, Inc.
2020
Asset Purchase Agreement between Sonoma Pharmaceuticals, Inc. and Infinity Labs SD Inc., dated June 24, 2020
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020
Separation and Release Agreement between the Company and Dr. Robert Northey, dated May 29, 2020
Separation Agreements
Sonoma Pharmaceuticals, Inc.
2020
Consulting Agreement between the Company and Dr. Robert Northey, dated May 30, 2020
Consulting Agreements
Sonoma Pharmaceuticals, Inc.
2020
License, Distribution and Supply Agreement by and between Sonoma Pharmaceuticals, Inc. and Brill International, S.L. dated May 19, 2020
License Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2020
Consulting Agreement between the Company and TechCXO, LLC effective April 14, 2020
Consulting Agreements
Sonoma Pharmaceuticals, Inc.
2020
Mutual Separation and Release Agreement between the Company and John Dal Poggetto, dated April 14, 2020
Separation Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2020
Asset Purchase Agreement dated February 21, 2020, between Sonoma Pharmaceuticals, Inc. and Microsafe Group, DMCC
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2020
Employment Agreement between Sonoma Pharmaceuticals, Inc. and Amy Trombly, effective December 26, 2019
Employment Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2019
Form of Placement Agent Warrant granted to Dawson James Securities, Inc. in connection with the November 2019 public offering
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
2019
Placement Agency Agreement entered into by and between Sonoma Pharmaceuticals, Inc. and Dawson James Securities, Inc., as representative, dated November 26, 2019
Agency Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2019
Employment Agreement between Sonoma Pharmaceuticals, Inc. and Amy Trombly, effective September 25, 2019
Employment Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2019
Employment Agreement between Sonoma Pharmaceuticals, Inc. and John Dal Poggetto, effective September 25, 2019
Employment Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2019
Asset Purchase Agreement dated May 14, 2019, between Sonoma Pharmaceuticals, Inc. and Petagon, Ltd
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2019
Separation and Mutual Release between Sonoma Pharmaceuticals, Inc. and Jim Schutz, dated December 13, 2018
Separation Agreements
Sonoma Pharmaceuticals, Inc.
2018
Separation and Mutual Release between Sonoma Pharmaceuticals, Inc. and Robert E. Miller, dated December 13, 2018
Separation Agreements
Sonoma Pharmaceuticals, Inc.
2018
Employment Agreement between Sonoma Pharmaceuticals, Inc. and Frederick Sandford, effective December 11, 2018
Employment Agreements
Sonoma Pharmaceuticals, Inc.
2018
Form of Series C Warrant
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Form of Unit Purchase Option
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Placement Agency Agreement entered into by and between Sonoma Pharmaceuticals, Inc. and Dawson James Securities, Inc., as representative, dated November 16, 2018
Agency Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Warrant Agency Agreement by and among Sonoma Pharmaceuticals, Inc. and Computershare, Inc. and Computershare Trust Company, N.A., dated November 21, 2018
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Form of Series C Warrant
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Form of Representative's Unit Purchase Option
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
2018
Form of Placement Agency Agreement
Agency Agreements
Sonoma Pharmaceuticals, Inc.
2018
Form of Warrant Agency Agreement
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Form of Series C Warrant
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Commercial Lease (Georgia office) by and between Sonoma Pharmaceuticals, Inc. and PMR Holdings, LLC, dated May 1, 2018
Lease Agreements
Sonoma Pharmaceuticals, Inc.
2018
Exclusive License and Distribution Agreement entered into by and between Sonoma Pharmaceuticals, Inc. and EMS S.A. dated June 4, 2018
License Agreements
Sonoma Pharmaceuticals, Inc.
2018
Form of Placement Agent Warrant granted to Dawson James Securities, Inc. and The Benchmark Company, LLC in connection with the March 2, 2018 public offering, dated March 6, 2018
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Placement Agency Agreement entered into by and between Sonoma Pharmaceuticals, Inc. and Dawson James Securities, Inc. as representative of the placement agents, dated March 2, 2018
Agency Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Securities Purchase Agreement entered into by and between Sonoma Pharmaceuticals, Inc. and Montreux Equity Partners V, L.P., dated March 1, 2018
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
At Market Issuance Sales Agreement, dated December 8, 2017, by and between Sonoma Pharmaceuticals, Inc. and B. Riley FBR, Inc
Sales Agreements
Sonoma Pharmaceuticals, Inc.
2017
Specimen Common Stock Certificate
Stock Agreements
Sonoma Pharmaceuticals, Inc.
2017
Master Vendor Agreement by and between Sonoma Pharmaceuticals, Inc. and PetSmart Home Office, Inc., dated November 21, 2016
Sonoma Pharmaceuticals, Inc.
2017
Distribution Agreement by and between Sonoma Pharmaceuticals, Inc. and G. Pohl-Boskamp GmbH & Co. KG, dated April 13, 2016
Distribution Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2017
Amendment No. 8 to Office Lease Agreement by the between Oculus Innovative Sciences, Inc. and SSCOP Properties LLC, dated June 23, 2016
Lease Agreements
Sonoma Pharmaceuticals, Inc.
2017
EMPLOYMENT AGREEMENT
Employment Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2017
EMPLOYMENT AGREEMENT
Employment Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Sonoma Pharmaceuticals, Inc.
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2016
BACKGROUND
Sonoma Pharmaceuticals, Inc.
2016
BACKGROUND
Sonoma Pharmaceuticals, Inc.
2016
SECTION 382 RIGHTS AGREEMENT dated as of October 18, 2016 between OCULUS INNOVATIVE SCIENCES, INC. and COMPUTERSHARE INC., as Rights Agent
Registration Rights Agreements
Sonoma Pharmaceuticals, Inc.
2016
EMPLOYMENT AGREEMENT
Employment Agreements
Sonoma Pharmaceuticals, Inc.
2016
COMMON SHARE PURCHASE WARRANT OCULUSINNOVATIVE SCIENCES, INC.
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2016
EXCLUSIVE SALES AND DISTRIBUTION AGREEMENT
Sales Agreements
Sonoma Pharmaceuticals, Inc.
2016
UNDERWRITING AGREEMENT By and between OCULUS INNOVATIVE SCIENCES, INC. and DAWSON JAMES SECURITIES, INC., asRepresentative of the Several Underwriters
Underwriting Agreements
Sonoma Pharmaceuticals, Inc.
2016
OCULUS INNOVATIVE SCIENCES, INC. and COMPUTERSHAREINC. and ComputershareTRUST COMPANY, N.A. WARRANT AGREEMENT Dated as of March 18, 2016
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
2016
AMENDMENT NO. 1 TO SLA BRANDS, INC. SALES REPRESENTATION CONTRACT
Sales Agreements
Sonoma Pharmaceuticals, Inc.
2016
SECURITIES PURCHASE Follow-UpAGREEMENT
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
2015
SLA Brands, Inc. SALES REPRESENTATION CONTRACT
Sales Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2015
OCULUS INNOVATIVE SCIENCES, INC. UNDERWRITING AGREEMENT January 20, 2015
Underwriting Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2015
OCULUS INNOVATIVE SCIENCES, INC. and COMPUTERSHAREINC. and ComputershareTRUST COMPANY, N.A. WARRANT AGREEMENT Dated as of January 20, 2015
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
2015
COMMON STOCK PURCHASE WARRANT OCULUSINNOVATIVE SCIENCES, INC.
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
2015
COMMON STOCK PURCHASE WARRANT OCULUSINNOVATIVE SCIENCES, INC.
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2015
COMMON STOCK PURCHASE WARRANT OCULUSINNOVATIVE SCIENCES, INC.
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2015
COMMON STOCK PURCHASE WARRANT OCULUSINNOVATIVE SCIENCES, INC.
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
2015
COMMON STOCK PURCHASE WARRANT OCULUSINNOVATIVE SCIENCES, INC.
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2015
OCULUS INNOVATIVE SCIENCES, INC. UNDERWRITING AGREEMENT January ___,2015
Underwriting Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2015
OCULUS INNOVATIVE SCIENCES, INC. And COMPUTERSHAREINC. And ComputershareTRUST COMPANY, N.A. WARRANT AGREEMENT Dated as of [________], 2015
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2015
OCULUS INNOVATIVE SCIENCES, INC. UNDERWRITING AGREEMENT [____________], 2015
Underwriting Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2015
OCULUS INNOVATIVE SCIENCES, INC. And COMPUTERSHAREINC. And ComputershareTRUST COMPANY, N.A. WARRANT AGREEMENT Dated as of [________], 2015
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2015
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2015
OCULUS INNOVATIVE SCIENCES, INC. UNDERWRITING AGREEMENT [____________], 2015
Underwriting Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2015
OCULUS INNOVATIVE SCIENCES, INC. and COMPUTERSHAREINC. and ComputershareTRUST COMPANY, N.A. WARRANT AGREEMENT Dated as of [_____________], 2015
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
2015
COMMON STOCK PURCHASE WARRANT OCULUSINNOVATIVE SCIENCES, INC.
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2015
LEASE AGREEMENT BY AND BETWEEN 2500 YORK, L.P. ("Landlord") AND OCULUS INNOVATIVESCIENCES, INC. ("Tenant") FOR PROPERTYAT Suite 130, FirstFloor 2500 York Road Jamison, PA 18929...
Lease Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
PA
2014
OCULUS INNOVATIVE SCIENCES, INC. Common Stock (par value $0.0001 per share) At-the-Market Issuance Sales Agreement
Stock Agreements
Sonoma Pharmaceuticals, Inc.
2014
SERIES A COMMON STOCK PURCHASE WARRANT oculusinnovative sciences, inc.
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2014
SERIES B COMMON STOCK PURCHASE WARRANT oculusinnovative sciences, inc.
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
2014
COMMON STOCK PURCHASE WARRANT oculusinnovative sciences, inc.
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
2014
SECURITIESPURCHASE AGREEMENT
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2014
COMMON STOCK PURCHASE WARRANT oculusinnovative sciences, inc.
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2014
FUNDING AGREEMENT
Funding Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2014
AMENDED SEPARATION AGREEMENT
Separation Agreements
Sonoma Pharmaceuticals, Inc.
2014
AMENDMENT NO. 3 TO LICENSE AND SUPPLYAGREEMENT
License Agreements
Sonoma Pharmaceuticals, Inc.
2014
AMENDMENT NO. 1 TO SHARED SERVICES AGREEMENT
Services Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2014
FormOF SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2013
AMENDMENT NO. 1 TO LICENSE AND SUPPLY AGREEMENT
License Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2013
AMENDMENT NO. 2 TO LICENSE AND SUPPLYAGREEMENT
License Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2013
Oculus Innovative Sciences, Inc. 1129 North McDowell Boulevard Petaluma, CA 94954
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2013
Licenseand Supply Agreement
Supply Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2013
SEPARATION AGREEMENT
Separation Agreements
Sonoma Pharmaceuticals, Inc.
2013
EMPLOYMENT AGREEMENT
Employment Agreements
Sonoma Pharmaceuticals, Inc.
2013
EMPLOYMENT AGREEMENT
Employment Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2013
Licenseand Supply Agreement
Supply Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2013
SHARED SERVICES AGREEMENT
Services Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2013
EMPLOYMENT AGREEMENT
Employment Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2013
7,500,000Shares of Common Stock OCULUSINNOVATIVE SCIENCES, INC. UNDERWRITING AGREEMENT
Underwriting Agreements
Sonoma Pharmaceuticals, Inc.
2013
FORM OF REPRESENTATIVE’S WARRANT AGREEMENT
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
2013
ADDENDUM TO STANDARD INDUSTRIAL/COMMERCIALMULTI-TENANT LEASE-GROSS BY AND BETWEEN KCMKCPROPERTIES, LLP, AS LESSOR, AND OCULUS INC. A DELAWARE CORPORATION, AS LESSEE FOR THE...
Sonoma Pharmaceuticals, Inc.
2012
AMENDMENTTO LEASE DATED AUGUST 30, 2012 BY AND BETWEEN KCKMC PROPERTIES, LLC ("LESSOR") AND OCULUS, INC., A DELAWARE CORPORATION("LESSEE") FOR THEPROPERTY LOCATED AT 304565TH...
Lease Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2012
AMENDMENTNO. 7 TO LEASE
Lease Agreements
Sonoma Pharmaceuticals, Inc.
2012
STOCKPURCHASE AGREEMENT
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2012
Venture Lending & Leasing V, Inc. 104 La Mesa Dr., Suite 102 Portola Valley, CA 94028 October 30, 2012
Sonoma Pharmaceuticals, Inc.
2012
Venture Lending & Leasing VI, Inc. 104 La Mesa Dr., Suite 102 Portola Valley, CA 94028 October 30, 2012
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2012
License,Exclusive Distribution and Supply Agreement
Supply Agreements
Sonoma Pharmaceuticals, Inc.
2012
ExclusiveDistribution and Supply Agreement
Supply Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2012
COLLABORATION AGREEMENT
Collaboration Agreements
Sonoma Pharmaceuticals, Inc.
2012
FORM OF COMMON STOCK PURCHASE WARRANT oculusinnovative sciences, inc.
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2012
OCULUS INNOVATIVE SCIENCES, INC. CERTIFICATE OF DESIGNATIONOF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES A 0% CONVERTIBLEPREFERRED STOCK PURSUANT TO SECTION 151OF THE DELAWARE...
Stock Agreements
Sonoma Pharmaceuticals, Inc.
2012
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
2012
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF OCULUS INNOVATIVE SCIENCES, INC. (Void after November 30, 2018) _______________________________________________
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
2012
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF OCULUS INNOVATIVE SCIENCES, INC. (Void after November 30, 2018) _______________________________________________
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2011
PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT EXCLUSIVE COVER PAGE
License Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2011
DISTRIBUTION AGREEMENT
Distribution Agreements
Sonoma Pharmaceuticals, Inc.
2011
LOAN AND SECURITY AGREEMENT Dated as of June 29, 2011 between OCULUS INNOVATIVE SCIENCES, INC., a Delaware corporation, as Borrower, and VENTURE LENDING & LEASING VI, INC., a...
Loan Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2011
SUPPLEMENT
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2011
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF OCULUS INNOVATIVE SCIENCES, INC. (Void after November 30, 2018)
Warrant Agreements
Sonoma Pharmaceuticals, Inc.
2011
AMENDMENT NO. 1 TO LOAN DOCUMENTS
Loan Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2011
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Security Agreements
Sonoma Pharmaceuticals, Inc.
2011
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Security Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2011
AMENDMENT NO. 6 TO LEASE
Lease Agreements
Sonoma Pharmaceuticals, Inc.
2011
EXCLUSIVESALES AND DISTRIBUTION AGREEMENT
Distribution Agreements
Sonoma Pharmaceuticals, Inc.
2011
EXCLUSIVECO-PROMOTION AGREEMENT
Sonoma Pharmaceuticals, Inc.
2011
PRODUCTOPTION AGREEMENT
Sonoma Pharmaceuticals, Inc.
2011
DISTRIBUTIONAGREEMENT
Sonoma Pharmaceuticals, Inc.
2011
SECURITIESPURCHASE AGREEMENT
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2010
REGISTRATIONRIGHTS AGREEMENT
Registration Rights Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2010
PURCHASEAGREEMENT
Sonoma Pharmaceuticals, Inc.
2010
Exhibit10.1 CONTINUOUSOFFERING PROGRAM AGREEMENT
Sonoma Pharmaceuticals, Inc.
2010
AMENDMENTNO. 3 TO REVENUESHARING, PARTNERSHIP AND DISTRIBUTION AGREEMENT
Distribution Agreements
Sonoma Pharmaceuticals, Inc.
2010
LOANAND SECURITY AGREEMENT Datedas of May 3, 2010 between OCULUSINNOVATIVE SCIENCES, INC., aDelaware corporation, asBorrower, and VENTURELENDING & LEASING V, INC., aMaryland...
Security Agreements
Sonoma Pharmaceuticals, Inc.
2010
SUPPLEMENT tothe Loanand Security Agreement datedas of May 1, 2010 between OculusInnovative Sciences, Inc. (Borrower) and VentureLending & Leasing V, Inc. (Lender)
Security Agreements
Sonoma Pharmaceuticals, Inc.
2010
WARRANTTO PURCHASE SHARES OFCOMMON STOCK OF OCULUSINNOVATIVE SCIENCES, INC. (Voidafter November 30, 2017) _______________________________________________
Stock Agreements
Sonoma Pharmaceuticals, Inc.
2010
Common stock outstanding as of July 17, 2009
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2009
Common stock outstanding as of July 17, 2009
Stock Agreements
Sonoma Pharmaceuticals, Inc.
2009
Common stock outstanding as of June 15, 2009
Stock Agreements
Sonoma Pharmaceuticals, Inc.
2009
Common stock outstanding as of June 15, 2009
Stock Agreements
Sonoma Pharmaceuticals, Inc.
2009
Common stock outstanding as of June 15, 2009
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
DE
2009
We may move forward into the pivotal phase of our U.S. clinical program for Microcyn Technology
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2009
We may move forward into the pivotal phase of our U.S. clinical program for Microcyn Technology
Sonoma Pharmaceuticals, Inc.
2009
We may move forward into the pivotal phase of our U.S. clinical program for Microcyn Technology
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
DE
2009
We may move forward into the pivotal phase of our U.S. clinical program for Microcyn Technology
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2009
Common stock outstanding as of April 2, 2009
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2009
Entry Into a Material Definitive Agreement
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2009
Entry Into a Material Definitive Agreement
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2009
One hundred shares of our common stock, par value $0.0001 per share
Stock Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2009
PURCHASE AGREEMENT
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
2009
PURCHASE AGREEMENT
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2009
REVENUE SHARING DISTRIBUTION AGREEMENT
Distribution Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2009
Current assets
Sonoma Pharmaceuticals, Inc.
2008
Complete a meeting with FDA regarding our Phase II results and pivotal trial protocols
Sonoma Pharmaceuticals, Inc.
2008
Complete a meeting with FDA regarding our Phase II results and pivotal trial protocols
Sonoma Pharmaceuticals, Inc.
2008
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
Sonoma Pharmaceuticals, Inc.
2008
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
Sonoma Pharmaceuticals, Inc.
2008
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
Sonoma Pharmaceuticals, Inc.
2008
Securities Purchase Agreement, dated as of August 7, 2007
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
2007
Securities Purchase Agreement, dated as of August 7, 2007
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
2007
Securities Purchase Agreement, dated as of August 7, 2007
Purchase Agreements
Sonoma Pharmaceuticals, Inc.
2007
Initiate and complete Phase II trial for use of Microcyn in the treatment of infections in mildly infected diabetic foot ulcers
Sonoma Pharmaceuticals, Inc.
2007
Initiate and complete Phase II trial for use of Microcyn in the treatment of infections in mildly infected diabetic foot ulcers
Sonoma Pharmaceuticals, Inc.
2007
Initiate and complete Phase II trial for use of Microcyn in the treatment of infections in mildly infected diabetic foot ulcers
Sonoma Pharmaceuticals, Inc.
2007
Initiate and complete Phase II trial for use of Microcyn in the treatment of infections in mildly infected diabetic foot ulcers
Sonoma Pharmaceuticals, Inc.
2007
Exhibit No
Sonoma Pharmaceuticals, Inc.
2007
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
2006
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
2006
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
CA
2006
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
2006
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
2006
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
2006
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
2006
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
2006
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
2006
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
2006
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
2006
Geographic Region
Sonoma Pharmaceuticals, Inc.
2006
Geographic Region
Sonoma Pharmaceuticals, Inc.
2006
Geographic Region
Sonoma Pharmaceuticals, Inc.
2006
Geographic Region
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
Exhibit No
Sonoma Pharmaceuticals, Inc.
2007
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
2007
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
2006
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
2006
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
2006
Approval or Clearance Type
Sonoma Pharmaceuticals, Inc.
2006
Geographic Region
Sonoma Pharmaceuticals, Inc.
2006
Geographic Region
Sonoma Pharmaceuticals, Inc.
2006
Geographic Region
Sonoma Pharmaceuticals, Inc.
2006
Geographic Region
Sonoma Pharmaceuticals, Inc.
2006
Geographic Region
Sonoma Pharmaceuticals, Inc.
2006
Geographic Region
Sonoma Pharmaceuticals, Inc.
2006
Geographic Region
Sonoma Pharmaceuticals, Inc.
2006
Geographic Region
Sonoma Pharmaceuticals, Inc.
2006
Geographic Region
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006
many antiseptics, including Betadine, hydrogen peroxide and Dakins solution, are toxic, can destroy human cells and tissue, may cause allergic reactions and can impede the wound...
Sonoma Pharmaceuticals, Inc.
2006